Although further studies are necessary to further evaluate this hypothesis, the present results open new potential mechanisms in which CCN2, by increasing TβRII expression in VSMCs, could exert positive feedback in the TGF-β pathway activation, contributing to the TGF-β-beneficial effects described in some vasculopathy situations [70]. This evidence concerns the gene TGFB1 and vascular disorder.